GU Cancers 2023 | The unmet needs for immunotherapy in rare GU tumors

Talal El Zarif, MD, Dana-Farber Cancer Institute, Boston, MA, discusses unmet needs for immunotherapy in rare genitourinary tumors, particular penile cancer, including hurdles in accruing patients into clinical trials. Dr El Zarif additionally emphasizes the need for more translational studies to help understand why patients do not respond to immunotherapy. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.